http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2840273-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6636b59c3149a23a6ae7feaa3984d05f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-99001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
filingDate 2012-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0892ed21bfb3b0ebcd3c3f34f161c062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9283778de9e18c9db9cae0d4e980eab
publicationDate 2018-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2840273-C
titleOfInvention St6gal i mediated modulation of hematopoiesis
abstract Provided are methods for reducing haematocytes in an individual. The method involve administering to an individual a composition that contains recombinant a2,6-sialyltransferase (ST6Gal I). The method is suitable for prophylaxis and therapy of a condition that is positively correlated with undesirable hematopoiesis. Such conditions include autoimmune diseases, transplantation rejection, blood cancers and allergic reactions and inflammations. The invention also provides a pharmaceutical preparation that contains recombinant ST6Gal I and which is suitable for administration to an individual to reduce haematocytes in the individual, and a pharmaceutically acceptable carrier.
priorityDate 2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449719291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6480
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25610
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35834
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25197
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35833
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281096
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO02837
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO02708
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID608246
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57455154
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP97712
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09919
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6336541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID445376
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28746

Total number of triples: 42.